Yanagihara, Yoshihiro

Dr. Yoshihiro Yanagihara joined CICS in February 2018 as a researcher in the macrophage group.
After graduation from Hokkaido University (Japan) and qualifying the degree of Doctor of Veterinary in 2012, he began working for Kowa Company Ltd., and was assigned to Toxicology department at Fuji Research Laboratories. He was in charge of non-clinical safety evaluation for pemafibrate, a novel selective peroxisome proliferator-activated receptor alpha (PPARα) modulator.
At CICS, he has been working as a member of Professor Masanori Aikawa’s group. He is investigating the new therapeutic targets in pro-inflammatory activation of macrophages.

Publications

Show